SSHA

Society of Sexual Health Advisers

Unite the union
  • About us
    • JOIN SSHA
    • Code of Professional Conduct
    • National Organising Professional Committee
    • National Organising Professional Committee Structure
    • Constitution and Rules
    • Council Reports
    • NPC ACCESS ONLY
  • News
  • Regions
    • London
    • North East, Yorkshire & Humberside
    • Ireland
    • Scotland
    • South West
    • East Midlands – VACANT
    • North West
    • South East
    • Wales
    • West Midlands
  • Resources
    • I Want To Be A Health Adviser
    • SSHA Manual
    • Conference Presentations
    • Competency Framework for Sexual Health Advisers
    • WeSSI: West Sussex Sexual Health Structured Interview
    • Research
    • Unite – Union
    • Publications
  • Jobs
    • Current Jobs
    • Sample Job Descriptions
  • Links
Home » Scottish campaigners call for ‘immediate’ access to HIV prevention drug

Scottish campaigners call for ‘immediate’ access to HIV prevention drug

August 7, 2016 By SSHA Leave a Comment

George_Valiotis_SSHA

7th August 2016
by Judith Duffy [Herald Scotland]
Article Link

Campaigners have called on the Scottish Government to follow the example of France and introduce a drug that can prevent HIV without waiting for it to be licensed.

The drug, called Truvada, triggered headlines last week after the High Court told the NHS in England it should fund the treatment, despite health bosses arguing it was the responsibility of councils.

Critics argued the drug could lead to irresponsible sexual behaviour – with some describing it as a “lifestyle drug” – and would strain scarce NHS resources. The drug, which studies have found could reduce the risk of infection by nearly 90 per cent, is expected to be of most benefit for gay men who are at higher risk of contracting HIV.

Charity HIV Scotland said ministers north of the border should follow the example of France, which last year said it would make the drug available for free before it was fully licensed for prevention, as a pre-exposure prophylaxis medication (PrEP). Truvada was originally developed for the treatment of HIV.

George Valiotis, chief executive of HIV Scotland, said: “In France, the health minister said last year we are not going to wait for licensing, we are going to do this now as it can make a real difference to transmission rates.

“We would hope the Scottish Government would take the same approach and say we will act now.

“For the last 10 years, there have been between 350 and 370 new cases of HIV a year in Scotland – that is in spite of rigorous, well-organised behaviour change programmes for the last 30 years. In Scotland nearly one in four people who have HIV don’t know they have it.

“We need something else and the evidence for PrEP shows it works in particular cases.”

In a statement issued following the ruling, NHS England said it would appeal against the High Court ruling and warned that funding PrEP, which could cost £10-£20 million a year, would hit the money available for treatments for diseases.

Christian organisation CARE for Scotland, said it was “a lifestyle drug” that could increase the risk of sexually transmitted diseases.

But Valiotis said: “We have had a lot of people telling us they feel stigmatised about how this is being discussed,

“We were really shocked to see NHS England comparing it to other diseases – you don’t see that being done for other treatments.”

Some Scots are already using the drug. Gordon, who did not want his full name to be used, has been taking it on a daily basis since January. He obtains a generic form of PrEP online, which costs around £45 a month, but emphasises he still also has regular check-ups and monitoring at a sexual health clinic.

He said: “The difference it has made is it is a reassurance – I used to worry all the time. People can have the virus without knowing, so they may be unknowingly transmitting HIV and people are unknowingly being infected as they don’t know the status of their partners. I don’t feel so nervous now.

“I don’t use it on its own, I still use condoms, but it has given me reassurance so I don’t need to worry about it.

“I have always been cautious, but some of my friends have been cautious and ended up getting up HIV. This drug, if it is taken properly on a daily basis, can make a huge difference to people.”

He added: “I remember when the Aids epidemic was at its height and people were dying and it took a long time for drugs to be made available that were effective to treat HIV. Now they have something they can stop transmission – so why is there all this negativity about it?

“I am being responsible to myself, but I am also being responsible to my sexual partners.”

Dr Jamie Franks, a senior lecturer in the school of health and life sciences at Glasgow Caledonian University, who has carried out studies into PrEP, said research had estimated that treating HIV over a lifetime adds up to around £400,000 per person for the cost of the drugs alone. The cost of Truvada at the moment is around £400 a month.

He said: “PrEP is very cost-effective as long as we give it to the people who are most likely to become infected with HIV.”

On the issue of it being a “lifestyle” drug, Franks added: “If only we all heeded what all of the health psychologists tell us to do all of the time, we would all be a lot healthier.

“When it comes to HIV and sex, it is the same as alcohol and smoking, getting a suntan and eating too much.”

Ingrid Young, research fellow at the MRC/CSO Social and Public Health Sciences Unit at Glasgow University, said the drug had to be viewed as part of a comprehensive sexual health package.

“It is one of many options and will depend on the person and their circumstances and what suits them best,” she said.

“We offer a range of contraceptive options to women – and it is fantastic to finally be able to have a range of things to offer to people who may be at risk of HIV.”

The Scottish Medicines Consortium, which assesses if drugs should be made available on the NHS, said an application for Truvada as PrEP had yet to be submitted, but it would be assessed on the usual criteria, including cost-effectiveness.

Health Secretary Shona Robison said the European Medicines Agency recommended granting a marketing authorisation for Truvada’s use as PrEP on July 22, which has been sent to the European Commission for adoption.

She added: “We would urge the European Commission to do this quickly.

“As soon as Truvada is licenced for PrEP we will call on its manufacturer to submit an application to the Scottish Medicines Consortium, at a fair price, so its routine use in Scotland can be considered as quickly as possible.”

Filed Under: Media Watch Tagged With: CARE for Scotland, European Medicines Agency, France, gay men, George Valiotis, Glasgow Caledonian University, Glasgow University, High Court, hiv, HIV Scotland, Ingrid Young, Jamie Franks, MRC/CSO Social and Public Health Sciences Unit, msm, NHS, nhs england, prep, scottish government, Scottish Medicines Consortium, Shona Robinson, truvada

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.

About SSHA

The Society of Sexual Health Advisers (SSHA) is a UK national organisation with approximately 300 members out of an estimated 350 sexual health advisers in the country. It provides an opportunity for members to meet and work towards further professional development.

Recent Posts

  • Helping People to Reduce Sexual Health Risk: A Motivational Interviewing Approach February 28, 2023

Useful Links

  • BASHH
  • HPV Action
  • NAM
  • Public Health England
  • Public Health Scotland
  • Terence Higgins Trust
  • UNITE the Union

Copyright © 2023 · SSHA - Society of Sexual Health Advisers

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish.Accept Read More
Privacy & Cookies Policy

Privacy Overview

This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.
Necessary
Always Enabled
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
Non-necessary
Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.
SAVE & ACCEPT